Chad J. Kolean - 17 Jan 2023 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Chief Financial Officer
Signature
/s/ Christina Blakley, Attorney in-fact for Chad J. Kolean
Issuer symbol
CLRB
Transactions as of
17 Jan 2023
Net transactions value
$0
Form type
4
Filing time
18 Jan 2023, 17:33:02 UTC
Previous filing
15 Apr 2022
Next filing
12 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +104,000 $0.000000 104,000 17 Jan 2023 Common Stock 104,000 $1.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date.